Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• age 18 or older
• able to speak English or Spanish
• willing and able to sign informed consent, provide locator information and medical records release
• non-reactive result on rapid HIV test
• use of SSP to exchange syringes 2 times in the past 3 months
• planning to stay in the area for 12 months
Locations
United States
Florida
IDEA Miami
RECRUITING
Miami
IDEA Syringe Services Program
NOT_YET_RECRUITING
Miami
Contact Information
Primary
Hansel Tookes, MD
hetookes@med.miami.edu
3052431615
Time Frame
Start Date: 2024-10-07
Estimated Completion Date: 2027-10-09
Participants
Target number of participants: 350
Treatments
Experimental: Comprehensive Tele-harm Reduction
Participants will have enhanced access to a physician and clinical psychologist via remote video technology wherever the participant is located and prefers engagement (SSP, home, shelter, encampment). Participants will be in this group for 12 months.
Active_comparator: Off-site Linkage to HIV prevention
Participants in this group will receive off-site linkage to HIV care by having case management/social work services through our community engagement team. Participants will be in this group for 12 months.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: University of Miami